Evidence map›Paper›PMID 40878446›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Human Brain Cell-Type-Specific Aging Clocks Based on Single-Nuclei Transcriptomics.

Chandramouli Muralidharan, Enikő Zakar-Polyák, Anita Adami, Anna A Abbas, Yogita Sharma, Raquel Garza, Jenny G Johansson, Diahann A M Atacho, Éva Renner, Miklós Palkovits and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Human Brain Cell-Type-Specific Aging Clocks Based on Single-Nuclei Transcriptomics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chandramouli MuralidharanLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0003-2271-9609
Enikő Zakar-PolyákInstitute for Computer Science and Control (SZTAKI), Hungarian Research Network (HUN-REN), Budapest, 1111, Hungary.ORCID https://orcid.org/0000-0001-5655-4940
Anita AdamiLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0002-9421-7942
Anna A AbbasInstitute of Translational Medicine, Semmelweis University, Budapest, 1094, Hungary.ORCID https://orcid.org/0000-0002-6450-2208
Yogita SharmaLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0001-9702-1809
Raquel GarzaLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0002-2524-3055
Jenny G JohanssonLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0009-0007-2504-0067
Diahann A M AtachoLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0002-6158-0235
Éva RennerHuman Brain Tissue Bank, Semmelweis University, Budapest, 1094, Hungary.ORCID https://orcid.org/0000-0001-6957-8562
Miklós PalkovitsHuman Brain Tissue Bank, Semmelweis University, Budapest, 1094, Hungary.ORCID https://orcid.org/0000-0003-0578-0387
Csaba KerepesiInstitute for Computer Science and Control (SZTAKI), Hungarian Research Network (HUN-REN), Budapest, 1111, Hungary.ORCID https://orcid.org/0000-0001-9541-246X
Johan JakobssonLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0003-0669-7673
Karolina PircsLaboratory of Molecular Neurogenetics, Department of Experimental Medical Science, Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, 221 84, Sweden.ORCID https://orcid.org/0000-0001-8281-4785

Funding

Horizon 2020 Framework Programme 739593HUN-REN TKCS-2024/37International Center for Genetic Engineering and Biotechnology CRP/HUN21-05_ECMagyar Tudományos Akadémia HAS NAP2022-1-4/2022 NAP3.0Mesterséges Intelligencia Nemzeti Laboratórium RRF-2.3.1-21-2022-00004National Research, Development and Innovation Office 2023-2.1.2-KDP-2023-00016National Research, Development and Innovation Office FK_23_146912National Research, Development and Innovation Office TKP-NVA-20Vetenskapsrådet #2020-02247_3
6 · The paper itself

Abstract

Aging is the primary risk factor for most neurodegenerative diseases, yet the cell-type-specific progression of brain aging remains poorly understood. Here, human cell-type-specific transcriptomic aging clocks are developed using high-quality single-nucleus RNA sequencing data from post mortem human prefrontal cortex tissue of 31 donors aged 18-94 years, encompassing 73,941 high-quality nuclei. Distinct transcriptomic changes are observed across major cell types, including upregulation of inflammatory response genes in microglia from older samples. Aging clocks trained on each major cell type accurately predict chronological age, capture biologically relevant pathways, and remain robust in independent single-nucleus RNA-sequencing datasets, underscoring their broad applicability. Notably, cell-type-specific age acceleration is identified in individuals with Alzheimer's disease and schizophrenia, suggesting altered aging trajectories in these conditions. These findings demonstrate the feasibility of cell-type-specific transcriptomic clocks to measure biological aging in the human brain and highlight potential mechanisms of selective vulnerability in neurodegenerative diseases.

Indexed as

AgingBrainTranscriptomeAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMicrogliaMiddle AgedPrefrontal CortexYoung Adultaging clocksbiological clockshuman brain agingsingle nuclei sequencingtranscriptomic clocks

Identifiers

PMID40878446
PMCPMC12631854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.